hypoxanthine and Neuroblastoma
hypoxanthine has been researched along with Neuroblastoma in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Aglianò, AM; Barbato, S; Frati, L; Gazzaniga, P; Giacomello, A; Guaglianone, MR; Messina, E; Micheli, V; Morrone, S | 1 |
Barile, L; Giacomello, A; Lupi, F; Messina, E | 1 |
Chiba, P; Gharehbaghi, K; Lhotka, C; Pillwein, K; Ressmann, G; Schuchter, K; Szalay, SM; Szekeres, T | 1 |
Alfinito, P; Ledeen, RW; Lu, ZH; Wu, G | 1 |
Connolly, GP; Ma, MH; Stacey, NC | 1 |
Barankiewicz, J; Cohen, A; Kaplinsky, C; Yeger, H | 1 |
Other Studies
6 other study(ies) available for hypoxanthine and Neuroblastoma
Article | Year |
---|---|
Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines.
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hypoxanthine; Immunohistochemistry; Immunosuppressive Agents; Inhibitor of Apoptosis Proteins; Microfilament Proteins; Microtubule-Associated Proteins; Muscle Proteins; Mycophenolic Acid; Neoplasm Proteins; Neuroblastoma; Prodrugs; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins p21(ras); Reverse Transcriptase Polymerase Chain Reaction; Survivin; Time Factors; Tumor Suppressor Protein p53 | 2004 |
Potential role of mycophenolate mofetil in the management of neuroblastoma patients.
Topics: Allopurinol; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Guanine; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Immunosuppressive Agents; Mycophenolic Acid; Neuroblastoma; Niflumic Acid; Phenotype | 2004 |
Synergistic action of tiazofurin with hypoxanthine and allopurinol in human neuroectodermal tumor cell lines.
Topics: Allopurinol; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Guanosine Monophosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Neuroblastoma; Ribavirin; Tumor Cells, Cultured | 1993 |
Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Aminopterin; Binding, Competitive; Calcium Channels; Cholera Toxin; Cyclic AMP; Enkephalin, Leucine-2-Alanine; Fluorescent Dyes; G(M1) Ganglioside; Glioma; Hybrid Cells; Hypoxanthine; Neuroblastoma; Pertussis Toxin; Receptors, Opioid; Thymidine; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1997 |
Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome.
Topics: Animals; Cell Division; Culture Media; Energy Metabolism; Hypoxanthine; Lesch-Nyhan Syndrome; Neuroblastoma; Neurons; Rats; Tumor Cells, Cultured | 2001 |
Purine metabolism in human neuroblastoma cell lines.
Topics: Adenine; Adenosine; Cell Line; Guanosine; Humans; Hypoxanthine; Hypoxanthines; Neuroblastoma; Nucleosides; Purine Nucleosides; Purine Nucleotides; Purines; Tubercidin | 1986 |